Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ç¥À缺 ¹æ±¤Á¾¾ç¿¡¼­ BCG ÁÖÀÔ¿ä¹ý ÈÄ ¿ä°ü ÁÖÀ§¿¡ ¹ß»ýÇÑ °áÇÙ¼º À°¾ÆÁ¾¿¡ ÀÇÇÑ ¿ä°üÆó¼â Ureteral Obstruction Caused by Periureteral Tuberculous Granuloma after Intravesical BCG Therapy for Superficial Bladder Tumors

´ëÇѺñ´¢±â°úÇÐȸÁö 2006³â 47±Ç 4È£ p.436 ~ 439
³²»óº¹, ¹ÚÁ¤¼®, ±èÀçÁØ, ¹ÚÁØŹ, ³²»ï±Ø,
¼Ò¼Ó »ó¼¼Á¤º¸
³²»óº¹ ( Nam Sang-Bok ) 
¼­¿ïÀ§»ýº´¿ø ºñ´¢±â°ú

¹ÚÁ¤¼® ( Park Jung-Suk ) 
¼­¿ïÀ§»ýº´¿ø ºñ´¢±â°ú
±èÀçÁØ ( Kim Jae-Jun ) 
¼­¿ïÀ§»ýº´¿ø ºñ´¢±â°ú
¹ÚÁØŹ ( Park Jun-Tag ) 
¼­¿ïÀ§»ýº´¿ø ºñ´¢±â°ú
³²»ï±Ø ( Nam Sam-Keuk ) 
¼­¿ïÀ§»ýº´¿ø ºñ´¢±â°ú

Abstract


Bacillus Calmette-Guerin(BCG) is an attenuated strain of Mycobacterium bovis(M. bovis) that has been used to treat transitional cell carcinoma. Since the initial report by Morales and associates on the use of intravesical BCG for the treatment of recurrent superficial bladder tumors, intravesical therapy with BCG has proved to be more effective for prophylaxis and the treatment of superficial bladder tumors and carcinoma in situ than most of the standard chemotherapeutic agents. While the majority of patients tolerate BCG treatments well, a number of adverse reaction(e.g., fever, hematuria, dysuria, nausea and malaise) have been reported. More serious complications occur on rare occasions and they include pneumonitis/hepatitis, ureteral obstruction, renal abscess and sepsis. We report here on a case of ureteral obstruction that was caused by periureteral tuberculous granuloma after intravesical BCG therapy for superficial bladder tumors, and the condition required distal ureterectomy & ureteroneocystostomy. (Korean J Urol 2006;47:436-439)

Å°¿öµå

Mycobacterium bovis;Bladder neoplasms;Granuloma;Ureteral obstruction

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS